BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

288 related articles for article (PubMed ID: 10275201)

  • 1. Blues' cooperation, innovation key to retaining industry position.
    Richman D
    Mod Healthc; 1986 Jan; 16(3):40-1, 44-6. PubMed ID: 10275201
    [No Abstract]   [Full Text] [Related]  

  • 2. Challenge to Blues' tax-exemption seen as signal to healthcare industry.
    Anderson HJ; Baldwin MF
    Mod Healthc; 1985 Dec; 15(25):18-20. PubMed ID: 10274654
    [No Abstract]   [Full Text] [Related]  

  • 3. Blues' case management programs win support.
    Sandrick K
    Hospitals; 1987 Sep; 61(18):28, 32. PubMed ID: 3623463
    [No Abstract]   [Full Text] [Related]  

  • 4. Blues' cost-control claims stir debate.
    Cain C
    Bus Insur; 1983 Mar; 17(11):22-24. PubMed ID: 10258967
    [No Abstract]   [Full Text] [Related]  

  • 5. Court decisions give Blues plans one win, one loss in separate antitrust cases.
    Halper HR; Kazon PM
    Bus Health; 1987 Mar; 4(5):51-2. PubMed ID: 10280673
    [No Abstract]   [Full Text] [Related]  

  • 6. "Blues interfered illegally with HMO.".
    Burda D
    Mod Healthc; 1987 Nov; 17(24):12. PubMed ID: 10284683
    [No Abstract]   [Full Text] [Related]  

  • 7. Blues' HMOs enrollment increases to 1.2 million.
    Natl Underwrit Life Health; 1983 Apr; 87(14):28-9. PubMed ID: 10260349
    [No Abstract]   [Full Text] [Related]  

  • 8. The Blues' new colors.
    Frederiksen D
    Health Syst Rev; 1997; 30(4):18-21. PubMed ID: 10169728
    [No Abstract]   [Full Text] [Related]  

  • 9. Blues' loss could be hospitals' gain.
    Robinson ML
    Mod Healthc; 1982 Feb; 12(2):32. PubMed ID: 10298407
    [No Abstract]   [Full Text] [Related]  

  • 10. Blues' data bank: more clout, closer ties?
    Gallivan M
    Hospitals; 1986 May; 60(10):26, 28. PubMed ID: 3699726
    [No Abstract]   [Full Text] [Related]  

  • 11. Blues' second opinion plans growing but, so far, few are using option.
    Natl Underwrit Life Health; 1978 Sep; 82(38):6-7. PubMed ID: 10316688
    [No Abstract]   [Full Text] [Related]  

  • 12. Blues' discount policy seen as antitrust issue.
    Burda D
    Hospitals; 1986 Nov; 60(21):36. PubMed ID: 3770662
    [No Abstract]   [Full Text] [Related]  

  • 13. Are you paying for the Blues' new prosperity?
    Hunt K
    Med Econ; 1985 Aug; 62(16):50-5. PubMed ID: 10272459
    [No Abstract]   [Full Text] [Related]  

  • 14. Huge cost savings foreseen for Blues' two new programs.
    Staver S
    Am Med News; 1980 Jun; 23(24):1, 22-3. PubMed ID: 10247050
    [No Abstract]   [Full Text] [Related]  

  • 15. JCAHO to review Blues' HMOs.
    Burda D
    Mod Healthc; 1988 May; 18(19):5. PubMed ID: 10324573
    [No Abstract]   [Full Text] [Related]  

  • 16. Blues' president foresees negotiated fee plan. Interview by Sari Staver.
    McNerney WJ
    Am Med News; 1981 Aug; 24(31):3, 19. PubMed ID: 10324158
    [No Abstract]   [Full Text] [Related]  

  • 17. New quality program readies Blues' HMOs for competitive '90s.
    Johnsson J
    Contract Healthc; 1988 Aug; ():26-30. PubMed ID: 10290605
    [No Abstract]   [Full Text] [Related]  

  • 18. The Blues' blitz on health care costs.
    Demkovich LE
    Natl J (Wash); 1979 Jun; 11(22):902-6. PubMed ID: 10241583
    [No Abstract]   [Full Text] [Related]  

  • 19. The changing Blue Cross-provider relationship.
    Onusko TJ
    Healthspan; 1987; 4(8):14-7. PubMed ID: 10284579
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Maryland Blues' proposal criticized.
    Baldwin MF
    Mod Healthc; 1986 Jan; 16(2):18. PubMed ID: 10300559
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 15.